Exact Sciences Total Liabilities

Exact Sciences (EXAS) currently reports a total liabilities of $3.5B as of December 2025. That compares with $3.5B in the prior-year period — down 1.9% year over year. Use the charts on this page to explore Exact Sciences's total liabilities history and peer comparisons.

Exact Sciences's total liabilities decreased from $3.5B to $3.5B — a 1.9% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Exact Sciences reported $3.5B in total liabilities as of December 2025. That compares with $3.5B in the prior-year period — down 1.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $3.5B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Exact Sciences, and consider following EXAS for alerts when major investors trade the stock.

Exact Sciences is classified in the Healthcare sector. On total liabilities, it currently shows $3.5B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EXAS with unrelated industries.